Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 357 | 200 | 234 | 399 | 559 |
| Cost of Goods | 150 | 121 | 134 | 133 | 160 |
| Gross Profit | 220 | 79 | 100 | 266 | 410 |
| Operating Expenses | 1,480 | 928 | 1,129 | 548 | 1,170 |
| Operating Income | -1,123 | -728 | -895 | -149 | -611 |
| Interest Expense | 30 | 13 | 5 | 7 | 7 |
| Other Income | 53 | 66 | 46 | 2 | 18 |
| Pre-tax Income | -1,100 | -675 | -854 | -154 | -600 |
| Net Income Continuous | -4,455 | -675 | -854 | -154 | -1,758 |
| Net Income | $-4,455 | $-675 | $-854 | $-154 | $-1,758 |
| EPS Basic Total Ops | -1.26 | -0.84 | -1.40 | -0.28 | -0.14 |
| EPS Basic Continuous Ops | -1.26 | -0.79 | -1.46 | -0.32 | -0.14 |
| EPS Diluted Total Ops | -1.26 | -0.84 | -1.40 | -0.28 | -0.14 |
| EPS Diluted Continuous Ops | -1.26 | -0.79 | -1.46 | -0.32 | -0.14 |
| EBITDA(a) | $-1,057 | $-661 | $-835 | $-83 | $-541 |